Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Infections 1Hot Flashes 1Fever 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 67fludarabine phosphate 62Peripheral Blood Stem Cell Transplantation 51Mycophenolic Acid 44Cyclosporine 39Whole-Body Irradiation 38Antilymphocyte Serum 37Tacrolimus 36Busulfan 35Filgrastim 32Radiotherapy 29Methotrexate 23Methylprednisolone 22Melphalan 22Cord Blood Stem Cell Transplantation 21fludarabine 13Etoposide 12Psychiatric Rehabilitation 10Flow Cytometry 10Therapeutics 9Sirolimus 9Granulocyte Colony-Stimulating Factor 8Cytarabine 8Thiotepa 7Alemtuzumab 7Polymerase Chain Reaction 6thymoglobulin 5sargramostim 5Prednisone 5Cyclosporins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Mannose-Binding Lectin × Myeloid × Clear all
NCT00886496 2012-06-20

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Enzon Pharmaceuticals, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fever, Infections, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neutropenia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Hot Flashes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡